These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37720338)

  • 21. Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model.
    Yurchenko KS; Zhou P; Kovner AV; Zavjalov EL; Shestopalova LV; Shestopalov AM
    PLoS One; 2018; 13(4):e0195425. PubMed ID: 29621357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newcastle disease virus induces apoptosis in cisplatin-resistant human lung adenocarcinoma A549 cells in vitro and in vivo.
    Meng S; Zhou Z; Chen F; Kong X; Liu H; Jiang K; Liu W; Hu M; Zhang X; Ding C; Wu Y
    Cancer Lett; 2012 Apr; 317(1):56-64. PubMed ID: 22095029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.
    Koks CA; Garg AD; Ehrhardt M; Riva M; Vandenberk L; Boon L; De Vleeschouwer S; Agostinis P; Graf N; Van Gool SW
    Int J Cancer; 2015 Mar; 136(5):E313-25. PubMed ID: 25208916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment.
    Keshavarz M; Ebrahimzadeh MS; Miri SM; Dianat-Moghadam H; Ghorbanhosseini SS; Mohebbi SR; Keyvani H; Ghaemi A
    Virol J; 2020 May; 17(1):64. PubMed ID: 32370750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newcastle disease virus, rituximab, and doxorubicin combination as anti-hematological malignancy therapy.
    Al-Shammari AM; Rameez H; Al-Taee MF
    Oncolytic Virother; 2016; 5():27-34. PubMed ID: 27579294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
    Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
    Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-Deoxyglucose and Newcastle Disease Virus Synergize to Kill Breast Cancer Cells by Inhibition of Glycolysis Pathway Through Glyceraldehyde3-Phosphate Downregulation.
    Al-Shammari AM; Abdullah AH; Allami ZM; Yaseen NY
    Front Mol Biosci; 2019; 6():90. PubMed ID: 31612140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type I interferon-sensitive recombinant newcastle disease virus for oncolytic virotherapy.
    Elankumaran S; Chavan V; Qiao D; Shobana R; Moorkanat G; Biswas M; Samal SK
    J Virol; 2010 Apr; 84(8):3835-44. PubMed ID: 20147405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy.
    Huang F; Dai C; Zhang Y; Zhao Y; Wang Y; Ru G
    Front Mol Biosci; 2022; 9():889403. PubMed ID: 35860357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncolytic effects of the recombinant Newcastle disease virus, rAF-IL12, against colon cancer cells in vitro and in tumor-challenged NCr-Foxn1nu nude mice.
    Syed Najmuddin SUF; Amin ZM; Tan SW; Yeap SK; Kalyanasundram J; Veerakumarasivam A; Chan SC; Chia SL; Yusoff K; Alitheen NB
    PeerJ; 2020; 8():e9761. PubMed ID: 33354412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of a Recombinant Newcastle Disease Virus Expressing Human IL12 against Human Breast Cancer.
    Mohamed Amin Z; Che Ani MA; Tan SW; Yeap SK; Alitheen NB; Syed Najmuddin SUF; Kalyanasundram J; Chan SC; Veerakumarasivam A; Chia SL; Yusoff K
    Sci Rep; 2019 Sep; 9(1):13999. PubMed ID: 31570732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NDV-D90 inhibits 17β-estradiol-mediated resistance to apoptosis by differentially modulating classic and nonclassic estrogen receptors in breast cancer cells.
    Shan P; Tang B; Xie S; Zhang Z; Fan J; Wei Z; Song C
    J Cell Biochem; 2021 Jan; 122(1):3-15. PubMed ID: 32985706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic Suppression Effect on Tumor Growth of Colorectal Cancer by Combining Radiotherapy With a TRAIL-Armed Oncolytic Adenovirus.
    Gao H; Zhang X; Ding Y; Qiu R; Hong Y; Chen W
    Technol Cancer Res Treat; 2019; 18():1533033819853290. PubMed ID: 31138083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptin enhances the oncolytic properties of Newcastle disease virus.
    Wu Y; Zhang X; Wang X; Wang L; Hu S; Liu X; Meng S
    Intervirology; 2012; 55(4):276-86. PubMed ID: 21865658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncolytic effect of Newcastle disease virus is attributed to interferon regulation in canine mammary cancer cell lines.
    Santos MR; Xavier PLP; Pires PRL; Rochetti AL; Rosim DF; Scagion GP; de Campos Zuccari DAP; Munir M; Ferreira HL; Fukumasu H
    Vet Comp Oncol; 2021 Sep; 19(3):593-601. PubMed ID: 33871162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.
    Cheng X; Wang W; Xu Q; Harper J; Carroll D; Galinski MS; Suzich J; Jin H
    J Virol; 2016 Jun; 90(11):5343-5352. PubMed ID: 27009956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer.
    Chai Z; Zhang P; Fu F; Zhang X; Liu Y; Hu L; Li X
    Virol J; 2014 May; 11():84. PubMed ID: 24885546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the oncolytic potential of R
    Sharma KK; Kalyani IH; Mohapatra J; Patel SD; Patel DR; Vihol PD; Chatterjee A; Patel DR; Vyas B
    Arch Virol; 2017 Sep; 162(9):2705-2713. PubMed ID: 28578522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small molecules baicalein and cinnamaldehyde are potentiators of measles virus-induced breast cancer oncolysis.
    Kuo YT; Liu CH; Wong SH; Pan YC; Lin LT
    Phytomedicine; 2021 Aug; 89():153611. PubMed ID: 34144429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic suppression effect on tumor growth of hepatocellular carcinoma by combining oncolytic adenovirus carrying XAF1 with cisplatin.
    Ma B; Wang Y; Zhou X; Huang P; Zhang R; Liu T; Cui C; Liu X; Wang Y
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):419-29. PubMed ID: 25240826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.